| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
| 04/05/2007 | DE60124600T2 Zusammensetzungen und Verfahren zur Behandlung von Zuständen, die auf Östrogen ansprechen Compositions and methods for treating conditions responsive to estrogen |
| 04/05/2007 | DE10336497B4 Substituierte Pyridine und ein Verfahren zur Herstellung von substituierten Pyridinen Substituted pyridines and a process for preparing substituted pyridines |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/04/2007 | EP1770085A1 Diamine derivative, process for producing the same and fungicide containing the derivative as active ingredient |
| 04/04/2007 | EP1769795A2 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 04/04/2007 | EP1768962A1 Method for producing onium salts with a low chloride content |
| 04/04/2007 | EP1768654A2 Selective inhibitors of human corticosteroid syntheses |
| 04/04/2007 | EP1362033B1 Pyridine matrix metalloproteinase inhibitors |
| 04/04/2007 | CN1942473A Process for producing pentacyclic taxane |
| 04/04/2007 | CN1942469A Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
| 04/04/2007 | CN1942449A Process for preparing pyridazinone compounds |
| 04/04/2007 | CN1942444A Use of pyridindione derivatives for protecting organic material against detrimental effects of light |
| 04/04/2007 | CN1942443A Crystal of 1,2-dihydropyridine compound and method for producing same |
| 04/04/2007 | CN1942442A Insecticidal N-substituted sulfoximines |
| 04/04/2007 | CN1942436A Lysine based compounds |
| 04/04/2007 | CN1942434A Indene derivatives and process for the preparation thereof |
| 04/04/2007 | CN1942428A CETP inhibitors |
| 04/04/2007 | CN1939890A Production of secondary-amine compound |
| 04/04/2007 | CN1308331C Method of converting functional group through halogen-metal exchange reaction |
| 04/04/2007 | CN1308328C Novel process for the preparation of pyrazolopyrimidinones |
| 04/04/2007 | CN1308310C Nitrogenous aromatic ring compounds |
| 04/04/2007 | CN1308309C Process for preparing beta-ketoester compound |
| 04/04/2007 | CN1308302C Taxol enhancer compounds |
| 04/04/2007 | CN1308297C Phenyl sulfamate derivatives |
| 04/04/2007 | CN1307971C Antimycotic nail varnish composition |
| 04/03/2007 | US7199392 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylprimidines, and phenylquinolines and devices made with such compounds |
| 04/03/2007 | US7199265 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 04/03/2007 | US7199240 Reductive alkylation of saturated cyclic amines |
| 04/03/2007 | US7199239 Chemical compounds |
| 04/03/2007 | US7199158 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 04/03/2007 | US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists |
| 04/03/2007 | US7199134 Hydroxamic acid compounds and methods of use thereof |
| 04/03/2007 | CA2400945C Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 04/03/2007 | CA2294581C Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 03/29/2007 | WO2007035935A1 METHOD FOR 1H-IMIDAZO[4,5-c]PYRIDINES AND ANALOGS THEREOF |
| 03/29/2007 | WO2007035489A2 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents |
| 03/29/2007 | WO2007035428A1 Met kinase inhibitors |
| 03/29/2007 | WO2007034035A1 Sulphonamide derivatives |
| 03/29/2007 | WO2007019126A3 Method of preparation of azaindole derivatives |
| 03/29/2007 | WO2007015809A3 Hiv reverse transcriptase inhibitors |
| 03/29/2007 | WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/29/2007 | WO2006078676A3 Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/29/2007 | WO2006024841A3 Benzamide compounds |
| 03/29/2007 | US20070072942 Statin derivatives |
| 03/29/2007 | US20070072915 Novel phenoxyacetamide derivative and use thereof for preparation of diphenylamines |
| 03/29/2007 | US20070072914 11- beta -hydroxysteroid dehydrogenase type 1 enzyme inhibitor; antidiabetic agent, antidepressant; metabolic syndrome, insulin resistance syndrome, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, atherosclerosis, dementia |
| 03/29/2007 | US20070072905 Novel process for preparing dopenzil and its derivatives |
| 03/29/2007 | US20070072893 Substituted imidazo ring systems and methods |
| 03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
| 03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
| 03/29/2007 | US20070072833 Survivin inhibitors |
| 03/29/2007 | US20070069198 Synthesis of phenyl-substituted fluoranthenes by a diesel-alder reaction and the use thereof |
| 03/29/2007 | CA2623541A1 Method for 1h-imidazo[4,5-c]pyridines and analogs thereof |
| 03/29/2007 | CA2622086A1 Sulphonamide derivatives |
| 03/28/2007 | EP1767588A1 Dye and dye-sensitized solar cell |
| 03/28/2007 | EP1767527A1 Method for producing cyclic diamine derivative |
| 03/28/2007 | EP1765796A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 03/28/2007 | EP1765795A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 03/28/2007 | EP1765790A1 Azine-carboxamides as anti-cancer agent |
| 03/28/2007 | EP1765773A2 Amino, amino acid or peptide conjugates of retinoic acid |
| 03/28/2007 | EP1765771A2 Formation of tetra-substituted enamides and stereoselective reduction thereof |
| 03/28/2007 | EP1765768A1 Substituted acids for the treatment of respiratory diseases |
| 03/28/2007 | EP1765760A1 Phenyl derivatives comprising an acetylene group |
| 03/28/2007 | EP1499312B1 The use of hydroxypyridone-derivatives in wound healing |
| 03/28/2007 | EP1152760B1 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 03/28/2007 | CN1938244A Fluoridation method |
| 03/28/2007 | CN1935805A Pyrimidine derivative compound and its preparing method |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307162C Halogen-free ionic liquids |
| 03/28/2007 | CN1307161C Substituted dihydro 3-hylo-1H-pyrazoloe-5-carboxylates their prepn. and use |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1307156C Polyarylcarboxamides useful as lipid lowering agents |
| 03/28/2007 | CN1306995C Sonic method of enhancing chemical reactions |
| 03/27/2007 | US7196198 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196100 Opioid receptor antagonists |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | CA2396874C 4-aminopicolinates and their use as herbicides |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2193460C 3-amino-2-mercaptobenzoic acid derivatives and processes for their preparation |
| 03/22/2007 | WO2007032203A1 Process for production of ortho-metallized 1:3 complex of iridium with homoligand |
| 03/22/2007 | WO2007032016A1 An antimalarial baylis-hillman adducts and a process for the preparation thereof |
| 03/22/2007 | WO2007031791A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/22/2007 | WO2007031523A1 Fungicide pyridinyloxy substituted phenylamidine derivatives |
| 03/22/2007 | WO2006117609A3 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands |
| 03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
| 03/22/2007 | US20070066829 Methylene blue |
| 03/22/2007 | US20070066828 contacting pyridines or pyrimidines monomer with a particlulate catalyst containing metal or alloy (e.g. magnesium or alloy substrate) having a second reduced metal or alloy ( Ni, Cu, Co etc.) coated on the substrate to form dimer ( bi-pyridine) or polymer |
| 03/22/2007 | US20070066825 Chiral ligands and their transition metal complexes |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066822 Ionic liquids |
| 03/22/2007 | US20070066664 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses, materials for their synthesis |
| 03/22/2007 | US20070066658 N-{4-[4-(2-Benzylamino-ethyl)-phenoxy]-phenyl}-acetamide; eating disorders; antidiabetic, -arthritic, -epileptic, anxiolytic -lipedemic agents; anxiolytic, hypoglycemic and hypotensive agents; sexual disorders, antidepressants, hypertriglycemia, hyperlipoproteinemia, drug abuse; behavior disorders |
| 03/22/2007 | US20070066628 5-Aryl-indan-1-ol and analogs useful as progesterone receptor modulators |
| 03/22/2007 | US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 03/22/2007 | US20070066586 Aniline derivatives |